Insider Transactions in Q2 2025 at Encompass Health Corp (EHC)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2025
|
Mark J Tarr President & CEO |
SELL
Open market or private sale
|
Direct |
118,384
-9.17%
|
$14,324,464
$121.24 P/Share
|
|
May 20
2025
|
Mark J Tarr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
118,384
+8.79%
|
$4,616,976
$39.87 P/Share
|
|
May 14
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Bona fide gift
|
Direct |
3,667
-3.66%
|
-
|
|
May 06
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,279
-26.35%
|
$496,364
$116.61 P/Share
|
|
May 01
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+18.19%
|
-
|
|
May 01
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+7.12%
|
-
|
|
May 01
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+12.61%
|
-
|
|
May 01
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.81%
|
-
|
|
May 01
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+6.31%
|
-
|
|
May 01
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.98%
|
-
|
|
May 01
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.62%
|
-
|
|
Apr 30
2025
|
Patrick William Tuer EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,984
+23.15%
|
-
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-11.15%
|
$1,140,000
$114.79 P/Share
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.03%
|
$350,000
$35.06 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,575
-16.21%
|
$5,011,125
$115.55 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,575
+19.15%
|
$1,307,250
$31.0 P/Share
|
|
Apr 24
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
268
+5.1%
|
$27,336
$102.56 P/Share
|
|
Apr 22
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
360
+2.69%
|
$35,280
$98.23 P/Share
|
|
Apr 15
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.15%
|
-
|
|
Apr 15
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.17%
|
-
|
|
Apr 15
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.12%
|
-
|
|
Apr 15
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.16%
|
-
|
|
Apr 15
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.13%
|
-
|
|
Apr 15
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.16%
|
-
|
|
Apr 15
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.11%
|
-
|
|
Apr 15
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.17%
|
-
|
|
Apr 15
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.17%
|
-
|